US exempts select Indian specialty drugs, ingredients from 100% pharma tariff
The Economic Times has reported a new India-focused foreign affairs development: “US exempts select Indian specialty drugs, ingredients from 100% pharma tariff.” The publisher's feed describes the story as follows: The United States has provided a tariff exemption for certain specialty pharmaceuticals from India due to health needs. This exemption covers various pharmaceutical products, including those for rare diseases and nuclear medicines. Generics are not subject to the newly imposed pharma
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.



